What is the treatment for papular urticaria?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Papular urticaria is best treated with a combination of avoiding the insect causing the bites, topical treatments, and oral medications for symptom relief, with the most recent guidelines suggesting an "as much as needed and as little as possible" approach to pharmacologic treatment 1. To manage papular urticaria, it is essential to identify and eliminate the source of bites by:

  • Washing bedding in hot water
  • Vacuuming frequently
  • Using insect repellents containing DEET or permethrin on clothing and furniture For immediate symptom relief, apply:
  • Topical corticosteroids like hydrocortisone 1% cream 2-3 times daily for 5-7 days to reduce inflammation and itching
  • Topical antihistamines such as diphenhydramine, though they may cause sensitization For more severe cases, oral antihistamines like:
  • Cetirizine 10mg daily
  • Diphenhydramine 25-50mg every 6 hours can effectively control itching Antibiotics may be necessary if secondary bacterial infection develops, indicated by increased redness, warmth, or pus. Cool compresses and calamine lotion can provide additional relief. Treatment typically continues until the lesions resolve, usually within 1-2 weeks. The use of omalizumab, an anti-IgE antibody, has been shown to be effective in treating chronic spontaneous urticaria, and its use is recommended in the latest guidelines 1. It is crucial to note that the treatment approach should be individualized, and the patient's response to treatment should be closely monitored, with adjustments made as needed to ensure the best possible outcome in terms of morbidity, mortality, and quality of life.

From the FDA Drug Label

Uses temporarily relieves itching associated with minor skin irritations, inflammation, and rashes due to: eczema psoriasis poison ivy, oak, sumac insect bites detergents jewelry cosmetics soaps seborrheic dermatitis Directions for itching of skin irritation, inflammation, and rashes: adults and children 2 years of age and older: apply to affected area not more than 3 to 4 times daily

  • Papular urticaria is caused by insect bites, which is listed as one of the conditions that hydrocortisone (TOP) can temporarily relieve itching associated with.
  • The treatment for papular urticaria using hydrocortisone (TOP) would be to apply to the affected area not more than 3 to 4 times daily for adults and children 2 years of age and older 2 2.

From the Research

Treatment Options for Papular Urticaria

  • The mainstay of treatment for urticaria, including papular urticaria, is avoidance of triggers, although these can be identified in only 10 to 20 percent of patients with chronic urticaria 3, 4.
  • First-line pharmacotherapy for acute and chronic urticaria is nonsedating second-generation antihistamines (histamine H1 blockers), which can be titrated to larger than standard doses 3, 4, 5.
  • Other treatment options include:
    • First-generation antihistamines 3, 4, 6
    • Histamine H2 blockers 3, 4, 7
    • Leukotriene receptor antagonists 3, 4, 5
    • Brief corticosteroid bursts 3, 4, 7
    • Omalizumab, a humanized monoclonal anti-immunoglobulin E, for chronic urticaria that is unresponsive to H1 antagonists 5
    • Cyclosporine, for refractory chronic urticaria 4, 5

Special Considerations

  • In some cases, the combination of an antihistamine and an H2 antagonist may be effective, such as for symptomatic dermatographism 6.
  • For patients with refractory chronic urticaria, referral to subspecialists for additional treatments may be necessary 4.
  • It is essential to rule out anaphylaxis and consider specific underlying conditions that may be contributing to the urticaria 3, 4, 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Urticaria: evaluation and treatment.

American family physician, 2011

Research

Acute and Chronic Urticaria: Evaluation and Treatment.

American family physician, 2017

Research

Treatment of urticaria. An evidence-based evaluation of antihistamines.

American journal of clinical dermatology, 2001

Research

Diagnosis and treatment of urticaria in primary care.

Northern clinics of Istanbul, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.